Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study.
about
Serological detection of cutaneous T-cell lymphoma-associated antigensChemo-immunotherapy with oxaliplatin and interleukin-7 inhibits colon cancer metastasis in miceVaccination for melanoma.Modulating T-cell homeostasis with IL-7: preclinical and clinical studies.Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.Evaluation of biolistic gene transfer methods in vivo using non-invasive bioluminescent imaging techniquesPreventing relapse in melanoma.Advances in the non-surgical treatment of melanoma.Cytokines and antitumor immunity.Interleukin-7 inhibits tumor-induced CD27-CD28- suppressor T cells: implications for cancer immunotherapy.Immunotherapy for superficial bladder cancer.The evolving role of gene-based treatment in surgery.Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist.Tumor immune therapy: lessons from infection and implications for cancer - can IL-7 help overcome immune inhibitory networks?Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine.Requirement of interleukin 7 signaling for anti-tumor immune response under lymphopenic conditions in a murine lung carcinoma model.Comparative antitumor effect of preventive versus therapeutic vaccines employing B16 melanoma cells genetically modified to express GM-CSF and B7.2 in a murine modelEfficacy of cytokine gene transfection may differ for autologous and allogeneic tumour cell vaccines.Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.Phase I/II trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors: miscellaneous tumors.In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells.Surrogate markers of response to cancer immunotherapy
P2860
Q24544114-E7021849-F434-46E3-B5DA-EB38571ACB54Q28538913-F751EBA2-9A36-4E0F-B39B-44E88A294623Q30306588-C6C84F14-98FA-4AE1-A19E-C2DE48D2AE78Q33553984-F0E933E4-3CB8-4188-B482-6B0996E42614Q33680566-023FE522-9B72-4D44-8722-FD61A3BD2358Q33920307-9CD9E2AA-7E1C-4CD0-8AA9-7D82EF722228Q34107902-2F4D50C6-BC1B-4BA2-8C4F-955AF20A95C9Q34481976-4AA931EA-3EA5-434F-8DEC-58D4773660CEQ35142319-FAD3EF48-05A1-4128-AA0F-2A7C6BF7E6D6Q35146532-58EA082E-4D9A-41CC-A87B-FA4701E3496BQ35964134-6AFFE912-8F8E-4563-BEA7-717AEEE99B96Q36307508-C82CFB76-75E9-4DAF-ADA9-F4AABBD4A105Q36777133-F8C77956-7004-4123-933E-6CAC36B777FAQ37762226-FAF80939-41BB-4715-AD94-C0C03003C517Q38291127-190DA52B-58B4-4072-9C21-000A982B69D9Q38793983-646934F7-B4F5-4BD5-945C-CD165708D142Q39234383-FA35DAE7-514B-4615-A4DD-E209CA9B1777Q40819506-A8B68745-6287-43C6-84DA-707729D7B589Q42646887-824F1727-1455-4B0F-9FE6-FBC8EDED6B29Q45880048-75FF6EB6-9B37-4CF1-8FFE-59F847AEA47BQ53437611-23CDF4F7-93FC-4A6F-AB1F-0918E8B2535CQ58409657-60F459CC-8963-40A5-8518-F9A208DCC063
P2860
Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Vaccination with IL-7 gene-mod ...... tus: a clinical phase I study.
@ast
Vaccination with IL-7 gene-mod ...... tus: a clinical phase I study.
@en
type
label
Vaccination with IL-7 gene-mod ...... tus: a clinical phase I study.
@ast
Vaccination with IL-7 gene-mod ...... tus: a clinical phase I study.
@en
prefLabel
Vaccination with IL-7 gene-mod ...... tus: a clinical phase I study.
@ast
Vaccination with IL-7 gene-mod ...... tus: a clinical phase I study.
@en
P2093
P2860
P356
P1476
Vaccination with IL-7 gene-mod ...... tus: a clinical phase I study.
@en
P2093
Alijagic S
Jurgovsky K
Schadendorf D
P2860
P2888
P304
P356
10.1038/BJC.1998.317
P407
P577
1998-06-01T00:00:00Z